Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025
Go back to Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025| (NASDAQ: CTOR) | Delayed: 0.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.78 | 52 Week High | $ | |||
| Open | $0.78 | 52 Week Low | $ | |||
| Day High | $0.78 | P/E | N/A | |||
| Day Low | $0.78 | EPS | $ | |||
| Volume | 4 | |||||
| (NASDAQ: CTXR) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $2.50 | |||
| Open | $0.60 | 52 Week Low | $0.40 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $0.00 | |||
| Volume | 937 | |||||
